NeuroLeap, an applied neuroscience startup, has bagged an undisclosed amount of funding from Rajashree Birla, chairman of Aditya Birla Centre for Community Initiatives and Rural Development, and Sminu Jindal, MD at Jindal SAW, reported ET.
“People suffer from disorders like clinical depression for decades, but our solution has been proven to help patients over a period of a few months,” said Kumaar Bagrodia, founder of NeuroLeap.
“We will look to make this solution more accessible in the future, but even today we can deliver far better results than other methods for treating mental health conditions,” Bagrodia added.
NeuroLeap, headquartered in Mumbai, was started by Kumaar Bagrodia in 2016. The company NeuroLeap uses brain computer interface (BCI) technology to offer bespoke neural assessment and therapy for mental health conditions.
As per NeuroLeap’s website, the platform is leveraging the world’s best Brain Computer Interface technology to understand the human brain and help it work at peak potential based on the principles of neuroplasticity and operant conditioning using self regulation.
With clinics in Mumbai and Delhi, Neuro-Leap will expand its presence in the coming year to include a few more metro cities.